Data as of Apr 17
| +0.45 / +4.62%|
The 7 analysts offering 12-month price forecasts for Tetraphase Pharmaceuticals Inc have a median target of 17.00, with a high estimate of 25.00 and a low estimate of 16.00. The median estimate represents a +66.67% increase from the last price of 10.20.
The current consensus among 7 polled investment analysts is to Buy stock in Tetraphase Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.